Efficacy and Safety of DEB-TACE Combined With HAIC Versus HAIC Alone in Patients With Unresectable CRLM
Clinical trial NCT07031570 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07031570
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-01
- Primary completion
- 2025-09-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.